about
Metabolomics in rheumatic diseases: desperately seeking biomarkersMUC6 expression in breast tissues and cultured cells: abnormal expression in tumors and regulation by steroid hormones.Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liverJNK inhibition reduces apoptosis and neovascularization in a murine model of age-related macular degeneration.Choline kinase inhibition in rheumatoid arthritis.Paget's disease of bone in early adult life.Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.Epithelial Control of Gut-Associated Lymphoid Tissue Formation through p38α-Dependent Restraint of NF-κB Signaling.c-Jun N-Terminal Kinase in Inflammation and Rheumatic Diseases.NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha.Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis.Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis.Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus.Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.AMPK Activation by A-769662 Controls IL-6 Expression in Inflammatory Arthritis.Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.Distinct ON/OFF fluorescence signals from dual-responsive activatable nanoprobes allows detection of inflammation with improved contrast.Detection of Subclinical Arthritis in Mice by a Thrombin Receptor-Derived Imaging Agent.Synovial cell metabolism and chronic inflammation in rheumatoid arthritis.Occult liver involvement by polyarteritis nodosa.Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment.Imprint of human cytomegalovirus infection on the NK cell receptor repertoireAssociation of Atherosclerosis With Expression of the LILRB1 Receptor By Human NK and T-Cells Supports the Infectious Burden HypothesisNatural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarizationSerum metabolomic profiling predicts synovial gene expression in rheumatoid arthritisGranulomatous fasciitis followed by morphea profunda: Is granulomatous fasciitis part of a spectrum of deep morphea? A case report and review of the literatureHexokinase 2 as a novel selective metabolic target for rheumatoid arthritisCan Metabolic Pathways Be Therapeutic Targets in Rheumatoid Arthritis?[Chlorambucil in the treatment of secondary amyloidosis]Gout and secondary amyloid[Normotensive hydrocephalus and rheumatoid arthritis]Design of an anti-inflammatory diet (ITIS diet) for patients with rheumatoid arthritisDisease-Triggered Drug Release Effectively Prevents Acute Inflammatory Flare-Ups, Achieving Reduced DosingLiquid biopsies to guide therapeutic decisions in rheumatoid arthritisInterleukin-17 Inhibition in Spondyloarthritis Is Associated With Subclinical Gut Microbiome Perturbations and a Distinctive Interleukin-25-Driven Intestinal InflammationElevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell deathConstitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation
P50
Q26765005-E9B3C415-A891-4142-80B9-911D4ACDE4A0Q32058546-08A2A0A6-27A4-42AF-9B20-8B2ED790A331Q34471885-1CD826F9-EA94-4911-BAED-43505DB557C3Q34557890-3445919F-F894-481C-AA8B-B46796B57007Q35243831-8403C658-2C1C-451F-AFDA-2973C78D46E5Q35555156-478A92FE-109C-4F3C-A40B-61CBA3EB724DQ35678024-74C584B5-1014-427F-9A31-1E8B42F23A6FQ35899739-78B8DB56-ACFA-495D-A465-7F86C0B2D026Q36286056-5E879AEE-D3C8-4AD9-9B3A-84B3E92FABB3Q37158836-D38A9578-0F4B-4D22-AE5C-8551B7C1B6AAQ39343327-3CFF0D5F-5688-493C-83A5-EC82EC06959FQ39367839-94CAC56C-2618-403A-9260-1BFA7FFE206BQ40207796-BB5A1D60-F840-45E3-B2D9-706CA5BA210EQ40335295-17028E55-5183-4E82-B8DD-13A319052DE1Q40423409-B84E7A2D-992F-4F62-AD19-B2AE1F1673A3Q43511296-FAF3B8DE-A949-40DD-90E1-9A734020B735Q46102787-30C6C8CB-E9B0-4CD5-B5F6-A51824B0BAA5Q46872801-21934358-93EB-45AD-8774-101C9D703E9BQ51759451-BD3247BD-6E21-433D-97FE-8709411BC545Q53677215-319365CD-784D-4970-8C48-93D53135CB6AQ55394881-BDCB3E65-558C-491E-B0FC-F821AF08E620Q56169020-A69F2508-462D-42C3-8295-42375BD3DED0Q57200889-06F8EED7-D736-495B-8635-026677C0301FQ57200899-57C47CC9-C8D8-43AB-AB1F-E783219C3490Q58801311-E5CEFD6A-9561-4C43-8DC6-C466ACD7864EQ60191784-F338A3BD-8B3D-479D-8A29-237203819149Q64376788-3CAB4ACC-A78C-4B13-8AC7-E7F395A7C68AQ64885761-032A734D-FEC1-443D-9155-B924719DD4CCQ74017481-D6E5F4A6-B635-4CE4-9022-055D4DE9C309Q74628875-5B84A8B8-9367-43B7-80B8-56BFF6CDF5B7Q77334843-5F079999-B8F9-4400-8340-CDED7EDE588FQ89560820-D3BB132D-0CAA-405E-B951-50395CF4BD2FQ90227178-6C5134B3-9EC5-4FC1-BF71-178232FF1CF9Q90853964-DAD9D83A-D7EB-41A4-B604-D09586BAF4A4Q91291051-E7C84B14-BEB7-49A6-A2C7-E5332F7A9A18Q91410295-B1E6897F-06E3-47F5-9E26-2E05ECC8FC0DQ93562422-FA45409C-8F56-4C03-87FE-B25D050969F9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Monica Guma
@ast
Monica Guma
@en
Monica Guma
@es
Monica Guma
@nl
type
label
Monica Guma
@ast
Monica Guma
@en
Monica Guma
@es
Monica Guma
@nl
prefLabel
Monica Guma
@ast
Monica Guma
@en
Monica Guma
@es
Monica Guma
@nl
P106
P1153
6701922462
P31
P496
0000-0003-1951-9411